Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M64.2Revenue $M--Net Margin (%)--Altman Z-Score18.8
Enterprise Value $M38.8EPS $-1.6Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %--Quick Ratio15.0Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %189Current Ratio15.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-56.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-59.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M12.4ROIC % (ttm)-4,387.7Gross Margin Increase y-yN

Gurus Latest Trades with ONCS

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ONCS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ONCS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SLANSKY RICHARD BCFO 2015-07-06Buy150,000$6.12-15.03 view
DHILLON PUNITPresident and CEO 2015-06-10Buy2,500$6.74-22.85 view
MAIDA ANTHONY E IIIDirector 2014-03-20Buy22,800$0.81541.98 view
DHILLON PUNITPresident and CEO 2014-03-19Buy50,000$0.8550 view

Press Releases about ONCS :

Quarterly/Annual Reports about ONCS:

News about ONCS:

Articles On GuruFocus.com
sgen Jun 10 2015 
sgen Jun 10 2015 
Vista Partners Initiates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20 Jan 13 2015 
Portfolio 1 Jan 03 2015 

More From Other Websites
The NASDAQ Biotech Index Is Partying Like It's 1999 - Some Say The Party's Just Getting Started,... Aug 24 2015
OncoSec Promotes Sheela Mohan-Peterson to Chief Legal and Compliance Officer Aug 24 2015
OncoSec Promotes Sheela Mohan-Peterson to Chief Legal and Compliance Officer Aug 24 2015
OncoSec Announces First Patient Enrolled in Phase II Clinical Trial Evaluating Combination of... Aug 18 2015
OncoSec Announces First Patient Enrolled in Phase II Clinical Trial Evaluating Combination of... Aug 18 2015
ONCOSEC MEDICAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Aug 05 2015
OncoSec Medical to Participate in Webcast on Advances in Cancer Immunotherapy Jul 23 2015
OncoSec to Webcast Annual Meeting of Stockholders Jul 23 2015
OncoSec to Webcast Annual Meeting of Stockholders Jul 23 2015
OTC Markets Group Announces Second Quarter 2015 Index Performance and Rebalancing Jul 16 2015
OncoSec Medical to Participate in Webcast on Advances in Cancer Immunotherapy Jul 14 2015
Today's Bell Ringer, July 7 Jul 07 2015
OncoSec Medical Inc. (Nasdaq: ONCS) to Ring The Nasdaq Stock Market Opening Bell Jul 06 2015
OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell Jul 06 2015
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development Jul 06 2015
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development Jul 06 2015
OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell Jul 01 2015
ONCOSEC MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 25 2015
OncoSec Medical Appoints Richard B. Slansky as Chief Financial Officer Jun 25 2015
OncoSec Medical Appoints Richard B. Slansky as Chief Financial Officer Jun 25 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK